BEBPA 2018: Biopharmaceutical Discovery and Assay Development Using Acoustic Liquid Handling

Written by Labcyte on September 17, 2018

  • 332Shares

This year’s annual meeting of the European Bioassay Conference (BEBPA) is taking place in Budapest, Hungary, 26–28 September, and we’re excited for the opportunity to share our latest application for cellular bioassays.

New pharmaceuticals are tested for biological activity using cell-based potency assays. Automating these processes with acoustic liquid handling reduces cell-response variability and improves data quality. The ability to transfer nanoliter-scale liquids from any well to any other well is a unique feature of the acoustic energy-powered Echo® Liquid Handlers, enabling high-precision dispensing and assay miniaturisation.

The Echo Liquid Handler supports a full cellular workflow — from assay development to profiling activities — making it a suitable platform for the standardisation of regulatory compliance assays. If you’re attending BEBPA next week, stop by STAND 9 to learn more about Labcyte’s cell-based bioassay solutions. We’ll show you how to miniaturise your assays, taking them from 96 wells to 384 wells and beyond.

Be sure to join us for our featured talks:

27 September, 3:00 PM

Adventures in Liquid Handling (96- to 384-well format)
Paula Urquhart, Scientist, Covance

27 September, 4:00 PM

Standardization and Automation of QC Bioassays by Acoustic Dispensing
Aurore Lejeune-Dodge, Labcyte (UK)

We hope to see you there!

Add Comment

LOGIN to write a comment